Intraoperative Blood Loss clinical trials

Explore recruiting intraoperative blood loss clinical trials.

Recruiting intraoperative blood loss studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intraoperative Blood Loss trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Reduction of blood loss in pediatric osteotomies around the hip - A randomized placebo-controlled trial with tranexamic acid

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Pooled human plasma vs. Crystalloid in the fluid management of children undergoing instrumented spinal fusion for scoliosis. A double-blind, randomized clinical trial.

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Prevention of HEMOrhagic risk in upper MYOmeCTomy by use of Misoprostol.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Tranexamic Acid for reduction of intra- and postoperative TRansfusion Requirements in elective Abdominal surgery: randomized controlled trial (TATRA)

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Oral versus Intravenous Tranexamic Acid for Blood Loss Prevention in Off-Pump Coronary Artery Bypass Surgery: A Randomised Non-Inferiority Trial (TRANSCAB Study)

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A PHASE IB/II, OPEN-LABEL, MULTICENTER, RANDOMIZED PLATFORM STUDY EVALUATING THE EFFICACY AND SAFETY OF NEOADJUVANT IMMUNOTHERAPY COMBINATIONS IN PATIENTS WITH SURGICALLY RESECTABLE HEPATOCEULLULAR CARCINOMA (MORPHEUS-NEO HCC)

Austria, Spain, Germany, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Intraoperative Blood Loss trials by city

Intraoperative Blood Loss in Toronto Intraoperative Blood Loss in Vancouver Intraoperative Blood Loss in Montreal Intraoperative Blood Loss in Calgary Intraoperative Blood Loss in Edmonton Intraoperative Blood Loss in Ottawa Intraoperative Blood Loss in Winnipeg Intraoperative Blood Loss in Quebec City Intraoperative Blood Loss in Hamilton Intraoperative Blood Loss in Kitchener Intraoperative Blood Loss in London Intraoperative Blood Loss in Halifax Intraoperative Blood Loss in New York Intraoperative Blood Loss in Los Angeles Intraoperative Blood Loss in Chicago Intraoperative Blood Loss in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease